ubenimex has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, X; Li, H; Liu, K; Liu, Q; Meng, Q; Sun, H; Sun, P; Wang, C; Zhang, A; Zhu, Y | 1 |
| Jia, Y; Liu, K; Liu, Z; Shu, X; Wang, C; Wang, L | 1 |
2 other study(ies) available for ubenimex and Di Guglielmo Disease
| Article | Year |
|---|---|
Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Dogs; Drug Interactions; HEK293 Cells; Humans; In Vitro Techniques; Injections, Intravenous; Intestinal Absorption; Intestinal Mucosa; K562 Cells; Kidney; Leucine; Leukemia, Erythroblastic, Acute; Madin Darby Canine Kidney Cells; Male; Methotrexate; Organic Anion Transporters; Rats, Wistar; Renal Reabsorption; Tandem Mass Spectrometry; Transfection | 2014 |
Resveratrol Increases Anti-Proliferative Activity of Bestatin Through Downregulating P-Glycoprotein Expression Via Inhibiting PI3K/Akt/mTOR Pathway in K562/ADR Cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Caspases; Cell Proliferation; Cell Survival; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; K562 Cells; Leucine; Leukemia, Erythroblastic, Acute; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2016 |